Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Zealand Pharma

Director's Dealing • Apr 19, 2025

3391_rpt_2025-04-19_27e228fe-eed3-43bc-a2bc-37155ea1e087.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Adam
Krisko
Nygaard
2. Reason
for
the
notification
a) Position/status Employee
elected
member
of
the
Board		 of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
tion
monitor
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 1,217
d) Aggregated
information
-
Aggregated
volume		 1,217
-
Price		 DKK
516,616.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Adam
Steensberg
2. Reason
for
the
notification
a) Position/status Chief
Executive
Officer
b) Initial
notification/Amend
ment		 Initial
notification
3. Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
and Performance Share Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
Restricted Share Units
DKK
424.50		 37,980
Performance Share Units
DKK
424.50		 37,980
d) Aggregated
information
-
Aggregated
volume
-
Price		 Restricted Share Units:
37,980
and DKK 16,122,510
Performance Share Units:
37,980
and DKK 16,122,510
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Anneline
Nansen
2. Reason
for
the
notification
a) Position/status Employee
elected
member
of
the
Board
of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend
ment		 Initial
notification
3. Details
of
the
issuer,
emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
tion
monitor
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 1,217
d) Aggregated
information
-
Aggregated
volume
-
Price		 1,217
DKK
516,616.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Bernadette
Connaughton
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of		 Zealand
Pharma
A/S
b) Initial
notification/Amend
ment		 Initial
notification
3. Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive
program for 2025, whereby the instruments
grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,043
d) Aggregated
information
-
Aggregated
volume
-
Price		 3,043
DKK
1,291,753.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Elaine
Sullivan
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of		 Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
3. ment
Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,000
d) Aggregated
information
-
Aggregated
volume		 3,000
DKK
1,273,500
-
Price
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name: Enrique
Conterno
Martinelli
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of		 Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
3. ment
Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Stock
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,043
d) Aggregated
information
-
Aggregated
volume
-
Price		 3,043
DKK
1,291,753.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Frederik
Barfoed
Beck
2. Reason
for
the
notification
a) Position/status Employee
elected
member
of
the
Board		 of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
tion
monitor		 emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 1,217
d) Aggregated
information
-
Aggregated
volume		 1,217
-
Price		 DKK
516,616.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Henriette
Wennicke
2. Reason
for
the
notification
a) Position/status Chief
Financial
Officer
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,		 auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a)
Restricted
Share
Units
and Performance Share Units
Description
of
the
financial
instrument,
type
of
instru
ment
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units
and Performance Share Units
in
connection with Zealand Pharma's long-term incentive program for 2025,
whereby the instruments
grants the holder the right to receive shares in
Zealand Pharma, subject to the satisfaction of underlying vesting terms
and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
Restricted Share Units
DKK
424.50		 11,869
Performance Share Units
DKK
424.50		 11,869
d) Aggregated
information
-
Aggregated
volume
-
Price		 Restricted Share Units:
11,869
and DKK 5,038,390.50
Performance Share Units:
11,869
and DKK 5,038,390.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person
discharging
managerial
responsibilities/person
closely
associated
a) Name Jeffrey
Berkowitz
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of		 Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
tion
monitor		 emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,043
d) Aggregated
information
-
Aggregated
volume		 3,043
DKK
1,291,753.50
-
Price
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Kirsten
A.
Drejer
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
3. ment
Details
of
the
issuer,
emission
tion
monitor		 allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,043
d) Aggregated
information
-
Aggregated
volume
-
Price		 3,043
DKK
1,291,753.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Leonard
Kruimer
2. Reason
for
the
notification
a) Position/status Member
of
the
Board
of
Directors
of		 Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
tion
monitor		 emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 3,043
d) Aggregated
information
-
Aggregated
volume		 3,043
-
Price		 DKK
1,291,753.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Ludovic
Tranholm
Otterbein
2. Reason
for
the
notification
a) Position/status Employee
elected
member
of
the
Board
of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend		 Initial
notification
ment
3. Details
of
the
issuer,
tion
monitor		 emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
transaction(s):
of
transaction;
(iii)
each		 section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a)
Restricted
Share
Units
Description
of
the
financial
instrument,
type
of
instru
ment
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 1,217
d) Aggregated
information
-
Aggregated
volume		 1,217
-
Price		 DKK
516,616.50
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

1. Details
of
the
person		 discharging
managerial
responsibilities/person
closely
associated
a) Name Martin
Nicklasson
2. Reason
for
the
notification
a) Position/status Chairman
of
the
Board
of
Directors
of
Zealand
Pharma
A/S
b) Initial
notification/Amend
ment		 Initial
notification
3. Details
of
the
issuer,
tion
monitor		 emission
allowance
market
participant,
auction
platform,
auctioneer
or
auc
a) Name Zealand
Pharma
A/S
b) LEI 549300ITBB1ULBL4CZ12
4. Details
of
the
of
transaction;
(iii)
each		 transaction(s):
section
to
be
repeated
for
(i)
each
type
of
instrument;
(ii)
each
type
date;
and
(iv)
each
place
where
transactions
have
been
conducted
a) Description
of
the
financial
instrument,
type
of
instru
ment		 Restricted
Share
Units
Identification
code		 DK0060257814
b) Nature
of
the
transaction		 Grant of Restricted Share Units in connection with Zealand Pharma's long
term incentive program for 2025, whereby the instrument grants the holder
the right to receive shares in Zealand Pharma, subject to the satisfaction of
underlying vesting terms and other conditions.
c) Price(s)
and
volume(s)		 Price(s) Volume(s)
DKK
424.50		 6,086
d) Aggregated
information
-
Aggregated
volume
-
Price		 6,086
DKK
2,583,507
e) Date
of
the
transaction		 19
April
2025
f) Place
of
the
transaction		 Outside a trading venue, XOFF

More from Zealand Pharma

Major Shareholding Notification 2025
Oct 17
Major Shareholding Notification 2025
Oct 17
Major Shareholding Notification 2025
Oct 17
Declaration of Voting Results & Voting Rights Announcements 2025
Sep 30
Share Issue/Capital Change 2025
Sep 11
Major Shareholding Notification 2025
Aug 20
Major Shareholding Notification 2025
Aug 20
Major Shareholding Notification 2025
Aug 20
Earnings Release 2025
Aug 14
Earnings Release 2025
Aug 14
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.